Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress?

Henningfield, Jack E.; Fagerström, Karl

doi:10.1136/tc.10.3.253

Cited by 69 publications

(48 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A real-life long-term test of the concept of harm reduction has been ongoing in Sweden with little or no scientific monitoring (Henningfield & Fagerström 2001). Snus (oral moist snuff) has been produced in Sweden since the early 19th century.…”

Section: Introductionmentioning

confidence: 99%

Role of snus (oral moist snuff ) in smoking cessation and smoking reduction in Sweden

2003

View full text Add to dashboard Cite

AimsTo assess to what extent snus has been used as an aid to stop smoking among Swedish smokers. Design A random telephone retrospective survey of Swedish smokers and ex-smokers. Setting Survey conducted in November-December 2000. Participants A national sample of 1000 former and 985 current daily smokers aged 25-55 years. Measurements Smoking status, date and method of quitting by self-report. Findings Thirty-three per cent of former smokers and 27% of current smokers had ever used snus . The difference was larger among men (55% versus 45%, P = 0.003). Current smokers who made use of snus smoked on average fewer cigarettes per day than non-users of snus . The mean duration of abstinence among former smokers was not influenced by snus use. Conditionally on age, education and use of nicotine replacement therapy there was an increased probability of being a former rather than a current smoker with ever use (OR 1.72, 95% CI = 1.30-2.28) or current use (OR 1.81, 95% CI = 1.31-2.53) of snus . Having used snus at the latest quit attempt increased the probability of being abstinent by about 50% (OR 1.54, 95% CI = 1.09-2.20). Conclusions Our study suggests that by using snus , Swedish male smokers may increase their overall chances of abstinence. However, 71% of the men in this sample who quit smoking did so without using snus and the duration of abstinence was not affected by snus use. This suggests that snus is not a necessary component of smoking cessation at the population level. Snus use was very rare among women.

show abstract

Section: Introductionmentioning

confidence: 99%

Role of snus (oral moist snuff ) in smoking cessation and smoking reduction in Sweden

2003

View full text Add to dashboard Cite

show abstract

“…As most toxicity is related to the burning process, oral or unburned tobacco, or nicotine consumption, are suggested as being less harmful [25][26][27][28].…”

Section: Discussionmentioning

confidence: 99%

Nocturnal sleep-disturbing nicotine craving and accomplishment with a smoking cessation program

Riemerth

Kunze

Groman

2009

Wien Med Wochenschr

View full text Add to dashboard Cite

show abstract

“…Das größte Problem bei der Diskussion um die Zulassung von Oraltabak ist allerdings, dass man selbst bei staatlicher Regulation der Inhaltsstoffe einige Faktoren nicht abschätzen oder kontrollieren kann; dies sind beispielsweise die konkurrierenden kommerziellen Interessen der Tabakproduzenten und deren Marketingstrategien, die Einß ussnahme durch die Tabaklobby oder auch die Präferenzen der Bevölkerung hinsichtlich der Nikotinaufnahme (HenningÞ eld und Fagerström, 2001). Viele Erkenntnisse über die Wirkung rauchloser Tabakprodukte stützen sich bislang auf Erkenntnisse aus den USA und aus Schweden und es ist keinesfalls sicher, dass der Markt in Deutschland oder in anderen europäischen Län-dern auf eine Öffnung für Oraltabak ähnlich reagieren wür-de, insbesondere angesichts unterschiedlicher gesellschaftlicher und tabakkontrollpolitischer Rahmenbedingungen.…”

Section: Diskussionunclassified

Rauchlose Tabakprodukte und die Folgen ihres Gebrauchs für die Gesundheit

Mons

Straif

2007

J. Verbr. Lebensm.

View full text Add to dashboard Cite

Abkürzungen: IARC = International Agency for Research on Cancer; NNK = 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanon; NNN = N´-Nitrosonornikotin; TSNA = tabakspeziÞ sche Nitrosamine. Schlüsselwörter: Kautabak, Lutschtabak, Krebsrisiko, Rauchloser Tabak, Schnupftabak.Zusammenfassung: Rauchlose Tabakprodukte sind Schnupftabak, Kautabak und Lutschtabak. Diese werden konsumiert, ohne dass der Tabak verbrannt wird. Rauchlose Tabakprodukte enthalten tabakspeziÞ sche Nitrosamine und zahlreiche weitere karzinogene Substanzen sowie Zusatzstoffe. Epidemiologische Studien aus Nordamerika, Europa, Asien und Afrika zeigen hinreichende Evidenz, dass rauchloser Tabak Mundhöhlenkrebs und Bauchspeicheldrüsenkrebs verursacht. Eine bislang unklare Evidenzlage besteht für den Zusammenhang rauchlosen Tabaks mit kardiovaskulären Erkrankungen und Diabetes. Weiterhin gibt es Hinweise auf Schwangerschaftskomplikationen beim Konsum rauchloser Tabakprodukte bei schwangeren Frauen. Die Gesundheitsfolgen rauchloser Tabakprodukte werden schließlich kritisch vor dem Hintergrund der internationalen Debatte um eine Strategie der "harm reduction" diskutiert, derzufolge rauchloser Tabak als weniger gesundheitsschädliche Alternative zu Rauchwaren angeboten werden sollte. Abstract:Smokeless tobacco products include chewing tobacco, oral tobacco and snuff for inhalation. These products are consumed without burning the tobacco. Smokeless tobacco products contain tobacco speciÞ c nitrosamines and several other carcinogenic substances and additives. Epidemiologic studies from North America, Europe, Asia and Africa provide sufÞ cient evidence that smokeless tobacco causes oral cancer and cancer of the pancreas. The evidence for an association of smokeless tobacco with cardiovascular disease and diabetes is limited. Furthermore, there is some evidence for adverse pregnancy outcomes in pregnant women who use smokeless tobacco. The health consequences of smokeless tobacco products are discussed critically against the background of the international debate about a proposed strategy of harm reduction, which involves offering smokeless tobacco as a smoking cessation aid.

show abstract

Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress?

Cited by 69 publications

References 27 publications

Role of snus (oral moist snuff ) in smoking cessation and smoking reduction in Sweden

Role of snus (oral moist snuff ) in smoking cessation and smoking reduction in Sweden

Nocturnal sleep-disturbing nicotine craving and accomplishment with a smoking cessation program

Rauchlose Tabakprodukte und die Folgen ihres Gebrauchs für die Gesundheit

Contact Info

Product

Resources

About